Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Molecular Imaging to Identify Patients With Metastatic Breast Cancer Who Benefit From Endocrine Treatment Combined With Cyclin-Dependent Kinase InhibitionEur. J. Cancer 2020 Feb 01;126(xx)11-20, J Boers, CM Venema, EFJ de Vries, AWJM Glaudemans, TC Kwee, E Schuuring, JWM Martens, SG Elias, GAP Hospers, CP Schröder
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.